Upregulation of NHE9 has been recently linked to tyrosine kinase inhibitors resistance in oesophageal squamous cell carcinoma and glioblastomas as well as tumour growth and chemoresistance in glioblastomas25. The gene discussed is SLC9A9; the disease is glioblastoma.